188 related articles for article (PubMed ID: 30316363)
1. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
2. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
3. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
[TBL] [Abstract][Full Text] [Related]
4. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
[TBL] [Abstract][Full Text] [Related]
5. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
[TBL] [Abstract][Full Text] [Related]
6. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.
Wiebe C; Pochinco D; Blydt-Hansen TD; Ho J; Birk PE; Karpinski M; Goldberg A; Storsley LJ; Gibson IW; Rush DN; Nickerson PW
Am J Transplant; 2013 Dec; 13(12):3114-22. PubMed ID: 24164958
[TBL] [Abstract][Full Text] [Related]
7. Epitope analysis of HLA-DQ antigens: what does the antibody see?
Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
[TBL] [Abstract][Full Text] [Related]
8. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
9. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
[TBL] [Abstract][Full Text] [Related]
10. HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.
Bosch A; Llorente S; Eguia J; Mrowiec A; Boix F; López-Hernández R; Campillo JA; Salgado G; Moya-Quiles MR; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Hum Immunol; 2014 Apr; 75(4):338-41. PubMed ID: 24486575
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA B- and T-cell molecular mismatches with HLA antibodies, rejection, and graft survival in pediatric kidney transplantation.
Gramkow AM; Baatrup JH; Gramkow ET; Thiesson HC; Koefoed-Nielsen P
Pediatr Transplant; 2024 Aug; 28(5):e14773. PubMed ID: 38808702
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
[TBL] [Abstract][Full Text] [Related]
13. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
15. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation.
Heilman RL; Nijim A; Desmarteau YM; Khamash H; Pando MJ; Smith ML; Chakkera HA; Huskey J; Valdez R; Reddy KS
Transplantation; 2014 Dec; 98(12):1310-5. PubMed ID: 24879384
[TBL] [Abstract][Full Text] [Related]
16. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines.
El-Awar N; Nguyen A; Almeshari K; Alawami M; Alzayer F; Alharbi M; Sasaki N; Terasaki PI
Hum Immunol; 2013 Sep; 74(9):1141-52. PubMed ID: 23756161
[TBL] [Abstract][Full Text] [Related]
17. Repeated human leukocyte antigens eplets, importance of typing the partner.
Dos Reis Ferreira C; da Silva Fernandes VM; Tafulo SCR; Cerqueira A; Rocha ACB; Nunes ATPM; Ferreira IPCN; Santos MJC; Pinho ATMT; Tavares IC; Guerra MMBB; Norton SMMS
Transpl Immunol; 2024 Jun; 84():102049. PubMed ID: 38729449
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
19. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]